Thomas Mok
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Tracheal and airway disorders
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Tuberculosis Research and Epidemiology 3
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Medical Imaging and Pathology Studies 1
- Co-authors
- Johnny Wai Man Chan (5 shared papers)Msm Ip (3 shared papers)C K Ng (3 shared papers)Kenneth W. Tsang (2 shared papers)G.C. Ooi (2 shared papers)Poon Chuen Wong (2 shared papers)Moira Chan‐Yeung (3 shared papers)SM Ng (1 shared paper)
- Journals
- Respirology (2 papers)Cytokine (1 paper)The International Journal of Tuberculosis and Lung Disease (1 paper)The Journal of Alternative and Complementary Medicine (1 paper)European Respiratory Journal (1 paper)
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Thomas Mok
14 papers receiving 435 citations
Peers
Comparison fields: 5 of 70
- Infectious Diseases 168
- Pulmonary and Respiratory Medicine 155
- Critical Care and Intensive Care Medicine 19
- Genetics 43
- Neurology 48
Countries citing papers authored by Thomas Mok
This map shows the geographic impact of Thomas Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mok more than expected).
Fields of papers citing papers by Thomas Mok
This network shows the impact of papers produced by Thomas Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mok. The network helps show where Thomas Mok may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Mok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 166 | |
| 2 | 2011 | 62 | |
| 3 | 2006 | 50 | |
| 4 | Bronchial artery embolisation can be equally safe and effective in the management of chronic recurrent haemoptysis. | 2008 | 45 |
| 5 | 2017 | 35 | |
| 6 | Pleuroscopy: our initial experience in Hong Kong. | 2008 | 24 |
| 7 | 2007 | 19 | |
| 8 | 2003 | 15 | |
| 9 | 2012 | 11 | |
| 10 | 2001 | 10 | |
| 11 | 2023 | 5 | |
| 12 | Seroprevalence of IgG antibody to SARS coronavirus (SARS-CoV) in a population-based sample of close contacts of all 1,755 cases in Hong Kong | 2004 | 4 |
| 13 | Benign metastasising leiomyoma: a rare but possible cause of bilateral pulmonary nodules in Chinese patients. | 2005 | 3 |
| 14 | 2023 | 1 | |
| 15 | Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis. | 2015 | 1 |
| 16 | 2019 | 0 |
About Thomas Mok
Thomas Mok is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Epidemiology, Surgery and Oncology, having authored 16 papers that have together received 451 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), COVID-19 Clinical Research Studies (2 papers), Diagnosis and treatment of tuberculosis (2 papers), Medical Imaging and Pathology Studies (1 paper), Endometrial and Cervical Cancer Treatments (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Infectious Diseases (168 citations), Pulmonary and Respiratory Medicine (155 citations), Critical Care and Intensive Care Medicine (19 citations), Genetics (43 citations) and Neurology (48 citations). Thomas Mok has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Johnny Wai Man Chan, Msm Ip, C K Ng, Kenneth W. Tsang, G.C. Ooi, Poon Chuen Wong, Moira Chan‐Yeung, SM Ng, Alice Jones and Hector W. H. Tsang. Their work appears in journals such as Respirology, Cytokine, The International Journal of Tuberculosis and Lung Disease, The Journal of Alternative and Complementary Medicine and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.